Search Results

One moment please while the data are loaded...

The DNTP Technical Report (TR) Level of Evidence Criteria are available here: https://ntp.niehs.nih.gov/go/baresults. In the table below this information is further delineated into three fields:

Level of Evidence: The overall category of evidence of carcinogenic activity for the TR, Species, Strain and Sex
Organ Site Call: The level of evidence supported by the specific organ site for the TR, Species, Strain and Sex. When the Organ Site Call directly supports the TR Level Of Evidence the Finding Type flag is set to “Neoplastic Lesion”. Some Organ Site Calls could support a separate call of Equivocal Evidence; this is noted in Finding Type by the flag “May Have Been Related”
Finding Type: Further identification of the Organ Site Call. Where this says “Neoplastic Lesion” the Organ Site Call supports the TR Level of Evidence and the Organ Site Call is the same as that of the TR. Where Finding Type says “May Have Been Related” the TR Level of Evidence for other responses led to an overall call of Clear or Some Evidence but the specified organ supports a call of Equivocal Evidence.

Displays results that match exactly with the given criteria.
Exact Match	Publication No.	CASRN	Test Article Name	Species	Strain	Sex	Route	Organ	Level of Evidence	Organ Site Call	Tumor Type/Incidence	Finding Type
Yes	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Clear Evidence	Equivocal Evidence	Squamous cell carcinoma: 0/52 0/52 3/52 1/52 1/52 0/52 1/50	May Have Been Related
Yes	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Clear Evidence	Clear Evidence	Carcinoma 2/52 2/52 1/52 3/52 4/52 3/52 11/50	Neoplastic Lesions
Yes	TR-561	119-64-2	Tetralin	Rats	F344/N	Female	Inhalation	Uterus	Some Evidence	Some Evidence	Stromal polyp 6/50 10/50 9/50 17/50	Neoplastic Lesions
Yes	TR-576	15625-89-5	Trimethylolpropane triacrylate	Mice	B6C3F1	Female	Topical Application	Uterus	Some Evidence	Some Evidence	stromal polyp or stromal sarcoma 0/50, 1/50, 2/50, 6/50	Neoplastic Lesions
Yes	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Female	Gavage	Uterus	Clear Evidence	Equivocal Evidence	stromal polyp or stromal sarcoma (original and residual evaluations, combined) 4/50 12/50 12/50 9/49	May Have Been Related
Yes	TR-584	700-06-1	Indole-3-carbinol	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Some Evidence	Some Evidence	adenocarcinoma (standard evaluation) 0/50 1/50 4/50 4/50 (standard and extended evaluations) combined 5/50 4/50 13/50 10/50	Neoplastic Lesions
Yes	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Female	Inhalation	Uterus	Some Evidence	Some Evidence	adenocarcinoma (1/50, 1/50, 0/50, 5/50); stromal polyp (7/50, 9/50, 16/50, 12/50)	Neoplastic Lesions
Yes	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence	Equivocal Evidence	Perinatal + Postweaning: adenocarcinoma (1/50, 3/50, 5/50)	May Have Been Related
Yes	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence	Equivocal Evidence	Postweaning: adenocarcinoma (1/50, 5/50, 8/50)	May Have Been Related
Yes	TR-587	79-94-7	Tetrabromobisphenol A	Rats	Wistar Han	Female	Gavage	Uterus	Clear Evidence	Clear Evidence	adenoma (original transverse review) 0/50 0/50 3/50 4/50 adenocarcinoma (original transverse review) 3/50 3/50 8/50 9/50 )original transverse and residual longitudinal reviews, combined) 4/50 10/50 15/50 16/50 malignant mixed Müllerian tumor (original transverse review) 0/50 4/50 0/50 2/50 adenoma, adenocarcinoma, or malignant mixed Müllerian tumor (original transverse review) 3/50 7/50 11/50 13/50 )original transverse and residual longitudinal reviews, combined) 6/50 11/50 16/50 19/50	Neoplastic Lesions
Yes	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Clear Evidence		adenoma, adenocarcinoma, squamous cell carcinoma, or squamous cell papilloma (combined) (3/50, 1/50, 1/50, 3/50, 7/50)	May Have Been Related
Yes	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Clear Evidence		adenoma, adenocarcinoma, squamous cell carcinoma, or squamous cell papilloma (combined) (2/50, 4/50, 1/50, 6/50, 13/50)	Neoplastic Lesions
Yes	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence		adenoma or adenocarcinoma (combined) (3/50, 4/50, 6/50, 8/49, 9/50)	Neoplastic Lesions

Displays all results in TRs which have data that match the given criteria.
Exact Match	Publication No.	CASRN	Test Article Name	Species	Strain	Sex	Route	Organ	Level of Evidence	Organ Site Call	Tumor Type/Incidence	Finding Type
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	All Organs	Clear Evidence		PERINATAL AND POSTWEANING STUDY (STUDY 1)	May Have Been Related
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	All Organs	Clear Evidence		POSTWEANING-ONLY STUDY (STUDY 2)	May Have Been Related
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	All Organs	Clear Evidence		PERINATAL AND POSTWEANING STUDY (STUDY 1)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	All Organs	Clear Evidence		POSTWEANING-ONLY STUDY (STUDY 2)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	All Organs	Clear Evidence		PERINATAL AND POSTWEANING STUDY (STUDY 1)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	All Organs	Clear Evidence		POSTWEANING-ONLY STUDY (STUDY 2)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Liver	Clear Evidence		hepatocellular adenoma (0/50, 0/50, 1/50, 1/50, 13/49); hepatocellular carcinoma (0/50, 0/50, 0/50, 0/50, 2/49); hepatocellular adenoma or carcinoma (combined) (0/50, 0/50, 1/50, 1/50, 14/49)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Liver	Clear Evidence		hepatocellular adenoma (1/49, 0/50, 5/50, 9/50, 5/48); hepatocellular carcinoma (0/49, 0/50, 0/50, 0/50, 8/48); hepatocellular adenoma or carcinoma (combined) (1/49, 0/50, 5/50, 9/50, 13/48)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Liver	Clear Evidence		hepatocellular adenoma (0/50, 2/50, 0/50, 1/50, 6/50); hepatocellular carcinoma (0/50, 0/50, 0/50, 0/50, 6/50); hepatocellular adenoma or carcinoma (combined) (0/50, 2/50, 0/50, 1/50, 12/50)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Liver	Clear Evidence		hepatocellular adenoma (0/50, 1/49, 0/50, 3/50, 8/49); hepatocellular carcinoma (1/50, 0/49, 0/50, 0/50, 3/49); hepatocellular adenoma or carcinoma (combined) (1/50, 1/49, 0/50, 3/50, 11/49)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence		acinar adenoma or carcinoma (combined) (0/49, 0/50, 0/50, 2/50, 1/48)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence		acinar adenoma or carcinoma (combined) (0/50, 0/50, 0/50, 1/50, 2/47)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence		acinar adenoma (10/50, 7/49, 8/50, 36/50, 22/49); acinar carcinoma (0/50, 0/49, 0/50, 3/50, 1/49); acinar adenoma or carcinoma (combined) (10/50, 7/49, 8/50, 38/50, 22/49)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence		acinar adenoma (1/49, 4/50, 5/50, 23/50, 30/50); acinar carcinoma (0/49, 1/50, 0/50, 1/50, 5/50); acinar adenoma or carcinoma (combined) (1/49, 5/50, 5/50, 23/50, 33/50)	Neoplastic Lesions
No	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Testis	Clear Evidence		interstitial cell, adenoma (7/50, 3/50, 3/50, 6/50, 15/50)	May Have Been Related
Yes	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Clear Evidence		adenoma, adenocarcinoma, squamous cell carcinoma, or squamous cell papilloma (combined) (3/50, 1/50, 1/50, 3/50, 7/50)	May Have Been Related
Yes	TR-601	117-81-7	Di(2-ethylhexyl) Phthalate	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Clear Evidence		adenoma, adenocarcinoma, squamous cell carcinoma, or squamous cell papilloma (combined) (2/50, 4/50, 1/50, 6/50, 13/50)	Neoplastic Lesions
No	TR-584	700-06-1	Indole-3-carbinol	Mice	B6C3F1	Male	Gavage	Liver	Clear Evidence	Clear Evidence	hepatocellular adenoma 26/50 32/50 31/49 41/50 hepatocellular carcinoma 12/50 11/50 29/49 14/50 hepatoblastoma 3/50 4/50 4/49 14/50 hepatocellular adenoma, hepatocellular carcinoma, or hepatoblastoma 36/50 36/50 44/49 45/50	Neoplastic Lesions
No	TR-584	700-06-1	Indole-3-carbinol	Rats	Harlan Sprague-Dawley	Female	Gavage	Skin	Some Evidence	Equivocal Evidence	fibroma 1/50 0/50 0/50 4/50 fibrosarcoma 1/50 0/50 0/50 1/50 fibroma or fibrosarcoma 2/50 0/50 0/50 5/50	May Have Been Related
Yes	TR-584	700-06-1	Indole-3-carbinol	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Some Evidence	Some Evidence	adenocarcinoma (standard evaluation) 0/50 1/50 4/50 4/50 (standard and extended evaluations) combined 5/50 4/50 13/50 10/50	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Female	Inhalation	Adrenal Gland Medulla	Some Evidence	Some Evidence	benign pheochromocytoma (0/49, 3/50, 4/50, 6/50)	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Mice	B6C3F1	Female	Inhalation	Harderian Gland	Clear Evidence	Clear Evidence	adenoma (2/50, 6/50, 6/50, 8/50); adenoma or adenocarcinoma (2/50, 6/50, 9/50, 8/50)	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Mice	B6C3F1	Female	Inhalation	Liver	Clear Evidence	Clear Evidence	hepatocellular adenoma (12/50, 14/50, 24/50, 34/50); hepatocellular carcinoma (7/50, 8/50, 12/50, 34/50); hepatoblastoma (0/50, 0/50, 1/50, 8/50)	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Mice	B6C3F1	Male	Inhalation	Liver	Clear Evidence	Clear Evidence	hepatocellular carcinoma (8/50, 19/50, 16/50, 35/50); hepatoblastoma (1/50, 1/50, 1/50, 15/50)	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Male	Inhalation	Lung	Some Evidence	Equivocal Evidence	alveolar/bronchiolar adenoma or carcinoma (0/50, 2/50, 0/50, 3/50)	May Have Been Related
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Female	Inhalation	Thyroid Gland C-Cell	Some Evidence	Some Evidence	adenoma (2/50, 8/50, 8/50, 14/50)	Neoplastic Lesions
No	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Male	Inhalation	Thyroid Gland C-Cell	Some Evidence	Some Evidence	adenoma (2/50, 5/49, 3/49, 12/50)	Neoplastic Lesions
Yes	TR-594	98-56-6	p-Chloro-a,a,a-trifluorotoluene	Rats	Harlan Sprague-Dawley	Female	Inhalation	Uterus	Some Evidence	Some Evidence	adenocarcinoma (1/50, 1/50, 0/50, 5/50); stromal polyp (7/50, 9/50, 16/50, 12/50)	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Mice	B6C3F1	Female	Gavage	Liver	Clear Evidence	Clear Evidence	hepatocellular adenoma 5/50 7/49 32/50 46/49 hepatocellular carcinoma 4/50 2/49 6/50 27/49 hepatocellular adenoma or carcinoma 8/50 8/49 33/50 47/49	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Mice	B6C3F1	Male	Gavage	Liver	Clear Evidence	Clear Evidence	hepatocellular adenoma 23/50 35/50 49/50 40/50 hepatocellular carcinoma 18/50 15/50 30/50 45/50 hepatocellular adenoma or carcinoma 31/50 40/50 49/50 47/50 hepatoblastoma 1/50 1/50 16/50 5/50 hepatocellular adenoma, hepatocellular carcinoma, or hepatoblastoma 31/50 40/50 49/50 47/50	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Female	Gavage	Liver	Clear Evidence	Clear Evidence	cholangiocarcinoma 0/50 0/49 0/50 2/47 hepatocholangioma 0/50 0/49 0/50 8/47 hepatocellular adenoma 3/50 2/49 8/50 16/47 hepatocellular carcinoma 0/50 0/49 1/50 6/47 hepatocellular adenoma or carcinoma 3/50 2/49 8/50 17/47) hepatocholangioma, hepatocellular adenoma, or hepatocellular carcinoma 3/50 2/49 8/50 21/47	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Male	Gavage	Liver	Clear Evidence	Clear Evidence	hepatocellular adenoma or carcinoma 3/49 2/50 4/50 9/50; hepatocholangioma, hepatocellular adenoma, or hepatocellular carcinoma 3/49 2/50 4/50 11/50	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Male	Gavage	Pituitary Gland	Clear Evidence	Clear Evidence	(pars distalis): adenoma 19/49 12/49 22/50 35/50	Neoplastic Lesions
No	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Male	Gavage	Thyroid Gland Follicular Cell	Clear Evidence	Clear Evidence	adenoma 1/45 3/45 2/48 6/46	Neoplastic Lesions
Yes	TR-589	32534-81-9	Pentabromodiphenyl Ether Mixture [DE-71 (Technical Grade)]	Rats	Wistar Han	Female	Gavage	Uterus	Clear Evidence	Equivocal Evidence	stromal polyp or stromal sarcoma (original and residual evaluations, combined) 4/50 12/50 12/50 9/49	May Have Been Related
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Unspecified	Clear Evidence		Not applicable	Not applicable
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Unspecified	Some Evidence		Not applicable	Not applicable
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Liver	Some Evidence	Equivocal Evidence	Perinatal + Postweaning: hepatocellular carcinoma (1/50, 0/50, 4/50)	May Have Been Related
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Liver	Some Evidence	Equivocal Evidence	Postweaning: hepatocellular carcinoma (1/50, 1/50, 3/49)	May Have Been Related
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	Perinatal + Postweaning: hepatocellular adenoma (0/50, 1/50, 5/50, 10/50); hepatocellular carcinoma (0/50, 0/50, 0/50, 4/50); hepatocellular adenoma or carcinoma (0/50, 1/50, 5/50, 12/50)	Neoplastic Lesions
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	Postweaning: hepatocellular adenoma (0/50, 0/50, 7/50, 11/50); hepatocellular carcinoma (0/50, 0/50, 0/50, 0/50); hepatocellular adenoma or carcinoma (0/50, 0/50, 7/50,11/50)	Neoplastic Lesions
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence	Clear Evidence	Postweaning: acinar cell adenoma (3/50, 28/50, 26/50, 32/50); acinar cell adenocarcinoma (0/50, 3/50, 1/50, 3/50), acinar cell adenoma or adenocarcinoma (3/50, 29/50, 26/50, 32/50)	Neoplastic Lesions
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Pancreas Acinar Cell	Clear Evidence	Clear Evidence	Perinatal + Postweaning: acinar cell adenoma (7/50, 18/50, 30/50, 30/50); acinar cell adenocarcinoma (0/50, 2/50, 1/50, 3/50), acinar cell adenoma or adenocarcinoma (7/50, 20/50, 30/50, 30/50)	Neoplastic Lesions
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Pancreas Acinar Cell	Some Evidence	Some Evidence	Postweaning: acinar cell adenoma (0/50, 0/50, 1/49); acinar cell adenocarcinoma (0/50, 0/50, 1/49); acinar cell adenoma or adenocarcinoma (0/50, 0/50, 2/49)	Neoplastic Lesions
No	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Pancreas Acinar Cell	Some Evidence	Some Evidence	Perinatal + Postweaning: acinar cell adenoma (0/50, 0/50, 3/50); acinar cell adenocarcinoma (0/50, 0/50, 2/50); acinar cell adenoma or adenocarcinoma (0/50, 0/50, 5/50)	Neoplastic Lesions
Yes	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence	Equivocal Evidence	Perinatal + Postweaning: adenocarcinoma (1/50, 3/50, 5/50)	May Have Been Related
Yes	TR-598	335-67-1	Perfluorooctanoic acid (PFOA)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence	Equivocal Evidence	Postweaning: adenocarcinoma (1/50, 5/50, 8/50)	May Have Been Related
No	TR-587	79-94-7	Tetrabromobisphenol A	Mice	B6C3F1/N	Male	Gavage	All Organs	Some Evidence	Equivocal Evidence	(Hemangiosarcoma) 1/50 5/50 8/50	May Have Been Related
No	TR-587	79-94-7	Tetrabromobisphenol A	Mice	B6C3F1/N	Male	Gavage	Intestines (Large)	Some Evidence	Equivocal Evidence	(cecum or colon) adenoma or carcinoma 0/50 0/50 3/50	May Have Been Related
No	TR-587	79-94-7	Tetrabromobisphenol A	Mice	B6C3F1/N	Male	Gavage	Liver	Some Evidence	Some Evidence	hepatoblastoma 2/50 11/50 8/50	Neoplastic Lesions
No	TR-587	79-94-7	Tetrabromobisphenol A	Rats	Wistar Han	Male	Gavage	Testis	Equivocal Evidence	Equivocal Evidence	interstitial cell, adenoma 0/50 0/50 1/50 3/50	May Have Been Related
Yes	TR-587	79-94-7	Tetrabromobisphenol A	Rats	Wistar Han	Female	Gavage	Uterus	Clear Evidence	Clear Evidence	adenoma (original transverse review) 0/50 0/50 3/50 4/50 adenocarcinoma (original transverse review) 3/50 3/50 8/50 9/50 )original transverse and residual longitudinal reviews, combined) 4/50 10/50 15/50 16/50 malignant mixed Müllerian tumor (original transverse review) 0/50 4/50 0/50 2/50 adenoma, adenocarcinoma, or malignant mixed Müllerian tumor (original transverse review) 3/50 7/50 11/50 13/50 )original transverse and residual longitudinal reviews, combined) 6/50 11/50 16/50 19/50	Neoplastic Lesions
No	TR-561	119-64-2	Tetralin	Rats	F344/N	Male	Inhalation	Kidney	Some Evidence	Some Evidence	Cortical renal tubule adenoma (standard evaluation) 0/50 1/50 1/50 2/50 standard and extended combined 0/50 3/50 2/50 6/50	Neoplastic Lesions
No	TR-561	119-64-2	Tetralin	Rats	F344/N	Female	Inhalation	Liver	Some Evidence	Some Evidence	Adenoma 0/50 0/50 0/50 3/50 adenoma or carcinoma 0/50 0/50 1/50 4/50	Neoplastic Lesions
No	TR-561	119-64-2	Tetralin	Mice	B6C3F1/N	Female	Inhalation	Spleen	Equivocal Evidence	Equivocal Evidence	Hemangiosarcoma 1/50 0/50 1/50 4/50	May Have Been Related
No	TR-561	119-64-2	Tetralin	Rats	F344/N	Male	Inhalation	Testis	Some Evidence	Equivocal Evidence	Adenoma, interstitial cell 29/50 39/50 31/50 41/50	May Have Been Related
Yes	TR-561	119-64-2	Tetralin	Rats	F344/N	Female	Inhalation	Uterus	Some Evidence	Some Evidence	Stromal polyp 6/50 10/50 9/50 17/50	Neoplastic Lesions
No	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Liver	Clear Evidence	Clear Evidence	Cholangiocarcinoma 0/52 0/51 0/52 0/52 3/52 36/49 29/49 adenoma 0/52 1/51 1/52 4/52 12/52 24/49 1/49 hepatocholangioma 0/52 0/51 0/52 0/52 0/52 4/49 0/49	Neoplastic Lesions
No	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Lung	Clear Evidence	Clear Evidence	Cystic keratinizing epithelioma 0/51 0/52 0/52 0/52 0/52 20/50 0/50	Neoplastic Lesions
No	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Pancreas Acinar Cell	Clear Evidence	Equivocal Evidence	Adenoma 0/52 0/52 0/52 2/52 3/52 1/47 0/49 adenoma or carcinoma 0/50 0/52 0/52 2/52 3/52 2/47 0/49	May Have Been Related
Yes	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Clear Evidence	Equivocal Evidence	Squamous cell carcinoma: 0/52 0/52 3/52 1/52 1/52 0/52 1/50	May Have Been Related
Yes	TR-559	31508-00-6	Toxic equivalency factor evaluation (PCB 118)	Rats	Harlan Sprague-Dawley	Female	Gavage	Uterus	Clear Evidence	Clear Evidence	Carcinoma 2/52 2/52 1/52 3/52 4/52 3/52 11/50	Neoplastic Lesions
No	TR-576	15625-89-5	Trimethylolpropane triacrylate	Mice	B6C3F1	Female	Topical Application	Liver	Some Evidence	Some Evidence	hepatoblastoma 0/50, 4/50, 0/50, 3/50; hepatocholangiocarcinoma 0/50, 0/50, 1/50, 2/50	Neoplastic Lesions
No	TR-576	15625-89-5	Trimethylolpropane triacrylate	Rats	F344/N	Male	Topical Application	Mesothelium (Abdominal Cavity/Tunica Vaginalis)	Equivocal Evidence	Equivocal Evidence	Malignant Mesothelioma 0/50, 2/50, 2/50, 5/50	May Have Been Related
Yes	TR-576	15625-89-5	Trimethylolpropane triacrylate	Mice	B6C3F1	Female	Topical Application	Uterus	Some Evidence	Some Evidence	stromal polyp or stromal sarcoma 0/50, 1/50, 2/50, 6/50	Neoplastic Lesions
No	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Liver	Some Evidence		hepatocellular adenoma (1/50, 3/50, 0/50, 3/50, 3/50)	May Have Been Related
No	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Mice	B6C3F1	Female	Dosed-Feed	Liver	Clear Evidence		hepatocellular adenoma (includes multiple) (11/50, 5/50, 13/50, 23/50); hepatocellular carcinoma (includes multiple) (1/50, 2/50, 5/50, 10/50); hepatocellular adenoma or carcinoma (combined) (12/50, 7/50, 16/50, 29/50)	Neoplastic Lesions
No	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Mice	B6C3F1	Male	Dosed-Feed	Liver	Some Evidence		hepatocellular carcinoma (includes multiple) (5/50, 14/50, 17/50, 14/50)	Neoplastic Lesions
No	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Rats	Harlan Sprague-Dawley	Male	Dosed-Feed	Liver	Some Evidence		hepatocellular adenoma or carcinoma (combined) (1/50, 0/50, 1/50, 7/50, 6/49)	Neoplastic Lesions
Yes	TR-602	13674-84-5	Tris(Chloropropyl) Phosphate (TCPP)	Rats	Harlan Sprague-Dawley	Female	Dosed-Feed	Uterus	Some Evidence		adenoma or adenocarcinoma (combined) (3/50, 4/50, 6/50, 8/49, 9/50)	Neoplastic Lesions